Cite
HARVARD Citation
Zhang, Y. et al. (2022). Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes. Neuro-oncology. 24 (10), pp. 1749-1762. [Online].